1. Boehm U, Bouloux PM, Dattani MT, de Roux N, Dode C, Dunkel L, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015; 11 (9): 547-564. doi: 10.1038/nrendo.2015.112.
2. Mitchell AL, Dwyer A, Pitteloud N, Quinton R. Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab. 2011; 22 (7): 249-258. doi: 10.1016/j.tem. 2011.03.002.
3. Grinspon RP, Loreti N, Braslavsky D, Valeri C, Schteingart H, Ballerini MG, et al. Spreading the clinical window for diagnosing fetal-onset hypogonadism in boys. Front Endocrinol (Lausanne). 2014; 5 51. doi: 10.3389/fendo.2014.00051.
4. Sykiotis GP, Hoang XH, Avbelj M, Hayes FJ, Thambundit A, Dwyer A, et al. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab. 2010; 95 (6): 3019-3027. doi: 10.1210/jc.2009-2582.
5. Pitteloud N, Quinton R, Pearce S, Raivio T, Acierno J, Dwyer A, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007; 117 (2): 457-463. doi: 10.1172/JCI29884.
6. Sykiotis GP, Plummer L, Hughes VA, Au M, Durrani S, Nayak-Young S, et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA. 2010; 107 (34): 15140-15144. doi: 10.1073/pnas.1009622107.
7. Miraoui H, Dwyer AA, Sykiotis GP, Plummer L, Chung W, Feng B, et al. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet. 2013; 92 (5): 725-743. doi: 10.1016/j.ajhg.2013.04.008.
8. Wang Y, Gong C, Qin M, Liu Y, Tian Y. Clinical and genetic features of 64 young male paediatric patients with congenital hypogonadotropic hypogonadism. Clin Endocrinol (Oxf). 2017; 87 (6): 757-766. doi: 10.1111/cen.13451.
9. Bouilly J, Messina A, Papadakis G, Cassatella D, Xu C, Acierno JS, et al. DCC/NTN1 complex mutations in patients with congenital hypogonadotropic hypogonadism impair GnRH neuron development. Hum Mol Genet. 2018; 27 (2): 359-372. doi: 10.1093/hmg/ddx408.
10. Quaynor SD, Bosley ME, Duckworth CG, Porter KR, Kim SH, Kim HG, et al. Targeted next generation sequencing approach identifies eighteen new candidate genes in normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Mol Cell Endocrinol. 2016; 437 86-96. doi: 10.1016/j.mce.2016.08.007.
11. Turan I, Hutchins BI, Hacihamdioglu B, Kotan LD, Gurbuz F, Ulubay A, et al. CCDC141 Mutations in Idiopathic Hypogonadotropic Hypogonadism. J Clin Endocrinol Metab. 2017; 102 (6): 1816-1825. doi: 10.1210/jc.2016-3391.
12. Suter T, Jaworski A. Cell migration and axon guidance at the border between central and peripheral nervous system. Science. 2019; 365 (6456): doi: 10.1126/science.aaw8231.
13. Zhu Z, Han X, Li Y, Han C, Deng M, Zhang Y, et al. Identification of ROBO1/2 and SCEL as candidate genes in Kallmann syndrome with emerging bioinformatic analysis. Endocrine. 2020; 67 (1): 224-232. doi: 10.1007/s12020-019-02010-y.
14. Barraud S, Delemer B, Poirsier-Violle C, Bouligand J, Merol JC, Grange F, et al. Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome. Neuroendocrinology. 2021; 111 (1-2): 99-114. doi: 10.1159/000506640.
15. Oleari R, Caramello A, Campinoti S, Lettieri A, Ioannou E, Paganoni A, et al. PLXNA1 and PLXNA3 cooperate to pattern the nasal axons that guide gonadotropin-releasing hormone neurons. Development. 2019; 146 (21): doi: 10.1242/dev.176461.
16. Howard SR. The Genetic Basis of Delayed Puberty. Front Endocrinol (Lausanne). 2019; 10 423. doi: 10.3389/fendo.2019.00423.
17. Zhu J, Choa RE, Guo MH, Plummer L, Buck C, Palmert MR, et al. A shared genetic basis for self-limited delayed puberty and idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2015; 100 (4): E646-654. doi: 10.1210/jc.2015-1080.
18. Au MG, Crowley WF, Jr., Buck CL. Genetic counseling for isolated GnRH deficiency. Mol Cell Endocrinol. 2011; 346 (1-2): 102-109. doi: 10.1016/j.mce.2011.05.041.
19. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003; 33 (4): 463-465. doi: 10.1038/ng1122.
20. Wang D, Niu Y, Tan J, Chen Y, Xu H, Ling Q, et al. Combined in vitro and in silico analyses of FGFR1 variants: genotype-phenotype study in idiopathic hypogonadotropic hypogonadism. Clin Genet. 2020; 98 (4): 341-352. doi: 10.1111/cge.13814.
21. Li S, Zhao Y, Nie M, Ma W, Wang X, Ji W, et al. Clinical Characteristics and Spermatogenesis in Patients with Congenital Hypogonadotropic Hypogonadism Caused by FGFR1 Mutations. Int J Endocrinol. 2020; 2020 8873532. doi: 10.1155/2020/8873532.
22. Pitteloud N, Hayes FJ, Boepple PA, DeCruz S, Seminara SB, MacLaughlin DT, et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002; 87 (1): 152-160. doi: 10.1210/jcem.87.1.8131.
23. Coutant R, Biette-Demeneix E, Bouvattier C, Bouhours-Nouet N, Gatelais F, Dufresne S, et al. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab. 2010; 95 (12): 5225-5232. doi: 10.1210/jc.2010-1535.
24. Adan L, Lechevalier P, Couto-Silva AC, Boissan M, Trivin C, Brailly-Tabard S, et al. Plasma inhibin B and antimullerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay. Med Sci Monit. 2010; 16 (11): CR511-517.
25. Rastrelli G, Corona G, Mannucci E, Maggi M. Factors affecting spermatogenesis upon gonadotropin-replacement therapy: a meta-analytic study. Andrology. 2014; 2 (6): 794-808. doi: 10.1111/andr.262.
26. Hao M, Nie M, Yu BQ, Gao YJ, Wang X, Ma WL, et al. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients. Asian J Androl. 2020; 22 (4): 390-395. doi: 10.4103/aja.aja_88_19.
27. Cerrato F, Shagoury J, Kralickova M, Dwyer A, Falardeau J, Ozata M, et al. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism. Eur J Endocrinol. 2006; 155 Suppl 1 S3-S10. doi: 10.1530/eje.1.02235.
28. Kim HG, Pedersen-White J, Bhagavath B, Layman LC. Genotype and phenotype of patients with gonadotropin-releasing hormone receptor mutations. Front Horm Res. 2010; 39 94-110. doi: 10.1159/000312696.
29. Bhagavath B, Ozata M, Ozdemir IC, Bolu E, Bick DP, Sherins RJ, et al. The prevalence of gonadotropin-releasing hormone receptor mutations in a large cohort of patients with hypogonadotropic hypogonadism. Fertil Steril. 2005; 84 (4): 951-957. doi: 10.1016/j.fertnstert.2005.04.029.
30. Young J, Bouligand J, Francou B, Raffin-Sanson ML, Gaillez S, Jeanpierre M, et al. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J Clin Endocrinol Metab. 2010; 95 (5): 2287-2295. doi: 10.1210/jc.2009-2600.
31. Topaloglu AK, Reimann F, Guclu M, Yalin AS, Kotan LD, Porter KM, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet. 2009; 41 (3): 354-358. doi: 10.1038/ng.306.
32. Gianetti E, Tusset C, Noel SD, Au MG, Dwyer AA, Hughes VA, et al. TAC3/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J Clin Endocrinol Metab. 2010; 95 (6): 2857-2867. doi: 10.1210/jc.2009-2320.
33. Avbelj Stefanija M, Jeanpierre M, Sykiotis GP, Young J, Quinton R, Abreu AP, et al. An ancient founder mutation in PROKR2 impairs human reproduction. Hum Mol Genet. 2012; 21 (19): 4314-4324. doi: 10.1093/hmg/dds264.
34. Sarfati J, Guiochon-Mantel A, Rondard P, Arnulf I, Garcia-Pinero A, Wolczynski S, et al. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab. 2010; 95 (2): 659-669. doi: 10.1210/jc.2009-0843.
35. Dode C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, et al. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet. 2006; 2 (10): e175. doi: 10.1371/journal.pgen.0020175.
36. Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab. 2008; 93 (9): 3551-3559. doi: 10.1210/jc.2007-2654.
37. Zhao Y, Wu J, Jia H, Wang X, Zheng R, Jiang F, et al. PROKR2 mutations in idiopathic hypogonadotropic hypogonadism: selective disruption of the binding to a Galpha-protein leads to biased signaling. FASEB J. 2019; 33 (3): 4538-4546. doi: 10.1096/fj.201801575R.
38. Bouty A, Ayers KL, Pask A, Heloury Y, Sinclair AH. The Genetic and Environmental Factors Underlying Hypospadias. Sex Dev. 2015; 9 (5): 239-259. doi: 10.1159/000441988.
39. Demirbilek H, Ozbek MN, Demir K, Kotan LD, Cesur Y, Dogan M, et al. Normosmic idiopathic hypogonadotropic hypogonadism due to a novel homozygous nonsense c.C969A (p.Y323X) mutation in the KISS1R gene in three unrelated families. Clin Endocrinol (Oxf). 2015; 82 (3): 429-438. doi: 10.1111/cen.12618.
40. Ji W, Zhang LY, Li FC, Wang Y, He W, Yin QQ, et al. Genetic sequencing of a patient with Kallmann syndrome plus 5alpha-reductase type 2 deficiency. Asian J Androl. 2017; 19 (3): 386-387. doi: 10.4103/1008-682X.170865.
41. Ayers KL, Bouty A, Robevska G, van den Bergen JA, Juniarto AZ, Listyasari NA, et al. Variants in congenital hypogonadotrophic hypogonadism genes identified in an Indonesian cohort of 46,XY under-virilised boys. Hum Genomics. 2017; 11 (1): 1. doi: 10.1186/s40246-017-0098-2.